STAT3, a transcription factor for acute phase response genes, acts as an adaptor molecule in signal transduction from the type I interferon receptor. They found that it binds to a conserved sequence in the cytoplasmic tail of the IFNAR1 chain of the receptor and undergoes interferon-dependent tyrosine phosphorylation. The p85 regulatory subunit of phosphatidylinositol 3-kinase, which activates a series of serine kinases, was found to bind to phosphorylated STAT3 and subsequently to undergo tyrosine phosphorylation. The authors concluded that STAT3 acts as an adaptor to couple another signaling pathway to the interferon receptor.In many human cancers and transformed cell lines, STAT3 is persistently activated, and in cell culture, active STAT3 is either required for transformation, enhances transformation, or blocks apoptosis.
Organism species: Homo sapiens (Human)
Organism species: Mus musculus (Mouse)
Organism species: Rattus norvegicus (Rat)
Organism species: Bos taurus; Bovine (Cattle)
- "Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway."Cell 77:63-71(1994) [PubMed] [Europe PMC] [Abstract]
- "Highly conserved amino-acid sequence between murine STAT3 and a revised human STAT3 sequence."Gene 213:119-124(1998) [PubMed] [Europe PMC] [Abstract]
- "Methods for treating chronic kidney disease."Patent number EP2440214, 18-APR-2012
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage." Nature 440:1045-1049(2006) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Requirement of serine phosphorylation for formation of STAT-promoter complexes."Science 267:1990-1994(1995) [PubMed] [Europe PMC] [Abstract]
- "Specific inhibition of Stat3 signal transduction by PIAS3."Science 278:1803-1805(1997) [PubMed] [Europe PMC] [Abstract]
- "Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation."Mol. Cell. Biol. 20:2043-2054(2000) [PubMed] [Europe PMC] [Abstract]
- "The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation."Biochem. Biophys. Res. Commun. 297:811-817(2002) [PubMed] [Europe PMC] [Abstract]
- "Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a."J. Biol. Chem. 277:8004-8011(2002) [PubMed] [Europe PMC] [Abstract]
- "Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation."J. Exp. Med. 196:641-653(2002) [PubMed] [Europe PMC] [Abstract]
- "A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R." J. Immunol. 168:5699-5708(2002) [PubMed] [Europe PMC] [Abstract]
- "Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor."Cancer Res. 63:3923-3930(2003) [PubMed] [Europe PMC] [Abstract]
- "Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway."Exp. Hematol. 31:398-405(2003) [PubMed] [Europe PMC] [Abstract]
- "Signal transduction via the stem cell factor receptor/c-Kit."Cell. Mol. Life Sci. 61:2535-2548(2004) [PubMed] [Europe PMC] [Abstract]
- "Characterization of the signaling capacities of the novel gp130-like cytokine receptor."J. Biol. Chem. 279:36112-36120(2004) [PubMed] [Europe PMC] [Abstract]
- "IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression."J. Biol. Chem. 279:51697-51703(2004) [PubMed] [Europe PMC] [Abstract]
- "TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3."Oncogene 23:8908-8919(2004) [PubMed] [Europe PMC] [Abstract]
- "Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation."Cancer Res. 65:5571-5577(2005) [PubMed] [Europe PMC] [Abstract]
- "Physical and functional interactions between STAT3 and ZIP kinase."Int. Immunol. 17:1543-1552(2005) [PubMed] [Europe PMC] [Abstract]
- "Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation."J. Biol. Chem. 280:13817-13823(2005) [PubMed] [Europe PMC] [Abstract]
- "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."Nat. Biotechnol. 23:94-101(2005) [PubMed] [Europe PMC] [Abstract]
- "Identification of STAT3 as a specific substrate of breast tumor kinase."Oncogene 25:4904-4912(2006) [PubMed] [Europe PMC] [Abstract]
- "Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer."Cancer Res. 67:8828-8838(2007) [PubMed] [Europe PMC] [Abstract]
- "STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3."Proc. Natl. Acad. Sci. U.S.A. 102:8150-8155(2005) [PubMed] [Europe PMC] [Abstract]
- "The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression."J. Biol. Chem. 282:37091-37102(2007) [PubMed] [Europe PMC] [Abstract]
- "Role for DYRK family kinases on regulation of apoptosis."Biochem. Pharmacol. 76:1389-1394(2008) [PubMed] [Europe PMC] [Abstract]
- "Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts."Blood 111:2310-2320(2008) [PubMed] [Europe PMC] [Abstract]
- "BART is essential for nuclear retention of STAT3."Int. Immunol. 20:395-403(2008) [PubMed] [Europe PMC] [Abstract]
- "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
- "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
- "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
- "The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth."Mol. Cancer Res. 7:142-155(2009) [PubMed] [Europe PMC] [Abstract]
- "Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity."J. Biol. Chem. 285:36129-36137(2010) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
- "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
- "Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells."J. Biol. Chem. 286:5956-5966(2011) [PubMed] [Europe PMC] [Abstract]
- "Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity."Mol. Cell 48:667-680(2012) [PubMed] [Europe PMC] [Abstract]
- "Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features."Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012) [PubMed] [Europe PMC] [Abstract]
- "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
- "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
- "STAT3 mutations in the hyper-IgE syndrome." N. Engl. J. Med. 357:1608-1619(2007) [PubMed] [Europe PMC] [Abstract]
- "Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome."Nature 448:1058-1062(2007) [PubMed] [Europe PMC] [Abstract]
- "Signal transducer and activator of transcription 3 mutation with invasive eosinophilic disease."Allergy Rhinol. (Providence) 3:E94-E97(2012) [PubMed] [Europe PMC] [Abstract]
- "Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease." Nat. Genet. 46:812-814(2014) [PubMed] [Europe PMC] [Abstract]